The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection

PACE - Pacing and Clinical Electrophysiology

Volumn 38, Issue 2, 2015, Pages 240-246

  Qintar, Mohammed ^a   Zardkoohi, Omeed ^b   Hammadah, Muhammad ^a   Hsu, Amy ^a   Wazni, Oussama ^a   Wilkoff, Bruce L ^a   Tarakji, Khaldoun G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Vascular and Interventional Program   (United States)

Author keywords

Cardiac implantable electronic device; complication; defibrillator; infection; outcome; pacemaker

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CHLORHEXIDINE; CREATININE; POVIDONE IODINE; WARFARIN; TOPICAL ANTIINFECTIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; ANTISEPSIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CREATININE BLOOD LEVEL; DEVICE INFECTION; DEVICE REMOVAL; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SKIN; AGE DISTRIBUTION; COHORT ANALYSIS; INCIDENCE; INTRADERMAL DRUG ADMINISTRATION; PREMEDICATION; PROCEDURES; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; RISK ASSESSMENT; SEX RATIO; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES;

ADMINISTRATION, CUTANEOUS; AGE DISTRIBUTION; AGED; ANTI-INFECTIVE AGENTS, LOCAL; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; MALE; OHIO; PACEMAKER, ARTIFICIAL; PREMEDICATION; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 84922619834     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12514     Document Type: Article

References (19)

1. Hayes DL, Furman S,. Cardiac pacing: How it started, where we are, where we are going. Pacing Clin Electrophysiol 2004; 27: 693-704.
2. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): Description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 2008; 5: 907-925.
3. Goldberger Z, Lampert R,. Implantable cardioverter-defibrillators: Expanding indications and technologies. J Am Med Assoc 2006; 295: 809-818.
4. Tarakji KG, Wilkoff BL,. Management of cardiac implantable electronic device infections: The challenges of understanding the scope of the problem and its associated mortality. Expert Rev Cardiovasc Ther 2013; 11: 607-616.
5. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, et al. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011; 58: 1001-1006.
6. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, et al. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010; 121: 458-477.
7. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation 2007; 116: 1349-1355.
8. Uslan DZ, Sohail MR, St Sauver JL, Friedman PA, Hayes DL, Stoner SM, Wilson WR, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: A population-based study. Arch Intern Med 2007; 167: 669-675.
9. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: Results from the REPLACE registry. Circulation 2010; 122: 1553-1561.
10. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J,. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29: 142-145.
11. Nery PB, Fernandes R, Nair GM, Sumner GL, Ribas CS, Menon SM, Wang X, et al. Device-related infection among patients with pacemakers and implantable defibrillators: Incidence, risk factors, and consequences. J Cardiovasc Electrophysiol 2010; 21: 786-790.
12. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis 2007; 45: 166-173.
13. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE,. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol 2005; 46: 1536-1540.
14. Uslan DZ, Gleva MJ, Warren DK, Mela T, Chung MK, Gottipaty V, Borge R, et al. Cardiovascular implantable electronic device replacement infections and prevention: Results from the REPLACE Registry. Pacing Clin Electrophysiol 2012; 35: 81-87.
15. Uslan DZ, Tleyjeh IM, Baddour LM, Friedman PA, Jenkins SM, St Sauver JL, Hayes DL,. Temporal trends in permanent pacemaker implantation: A population-based study. Am Heart J 2008; 155: 896-903.
16. Darouiche RO, Wall MJ Jr., Itani KM, Otterson MF, Webb AL, Carrick MM, Miller HJ, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010; 362: 18-26.
17. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, et al. Antibiotic prophylaxis for permanent pacemaker implantation: A meta-analysis. Circulation 1998; 97: 1796-1801.
18. de Oliveira JC, Martinelli M, Nishioka SA, Varejao T, Uipe D, Pedrosa AA, Costa R, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: Results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009; 2: 29-34.
19. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, Fraser TG, et al. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes. Heart Rhythm 2010; 7: 1043-1047.